35.62USD+3.13%Mkt Cap: 1.80B $P/E: —1d ago
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to …
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap1.80B $
Enterprise Value1.73B $
Revenue (TTM)552.16M $
Gross Profit400.78M $
Net Income (TTM)-11.45M $
Revenue/Share11.51 USD
Last Price35.62 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)102.15
PEG10.00
EV/EBITDA97.59
EV/Revenue3.14
P/S3.27
P/B3.67
EPS (TTM)-0.10
EPS (Forward)0.35
52W Range
25.3758% of range43.18
52W High43.18 USD
52W Low25.37 USD
Profitability
Gross Margin74.98%
Oper. Margin0.37%
EBITDA Margin3.21%
Profit Margin-2.14%
ROE-2.33%
ROA-1.75%
Growth
Revenue Growth14.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF57.33M $
CapEx (TTM)15.05M $
FCF Margin7.44%
FCF Yield2.28%
Net Debt-71.25M $
Net Debt/EBITDA-4.01
Balance Sheet
Debt/Equity0.15
Current Ratio4.29
Quick Ratio2.97
Book Value/Sh9.711 USD
Cash/Share2.886 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)47.00 USD
Upside (mean)+31.9%
Target Range36.00 USD – 55.00 USD
$36.00+31.9% to mean$55.00
# Analysts8
Ownership
Shares Out.50.64M
Float48.55M
Insiders3.86%
Institutions102.21%
Short Interest
Short Ratio4.5d
Short % Float9.15%
Short % Out.8.79%
Shares Short4.45M
Short (prev mo.)3.40M
Technical
SMA 5028.97 (+23.0%)
SMA 20033.05 (+7.8%)
Beta1.25
S&P 52W Chg20.25%
Avg Vol (30d)877.30K
Avg Vol (10d)866.41K
Technical Indicators
RSI (14)72.6
MACD1.8586
MACD Signal1.3512
MACD Hist.+0.5074
BB Upper36.80 USD
BB Middle30.94 USD
BB Lower25.09 USD
BB Width37.86%
ATR (14)1.420 USD
Vol Ratio (20d)0.69x